Daehan New Pharm Co. Ltd (054670) — Capital Reinvestment Ratio
Latest as of September 2025:
2.61x
Daehan New Pharm Co. Ltd (054670) has a Capital Reinvestment Ratio of 2.61x as of September 2025, meaning it reinvests 3% of its operating cash flow (₩4.43 Billion) in capital expenditures (₩11.53 Billion). See how much free cash does Daehan New Pharm Co. Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
2.61x
Capex / Operating Cash Flow
Operating Cash Flow
₩4.43 Billion
KRW
Capital Expenditures
₩11.53 Billion
KRW
Data as of
Sep 2025
Most recent filing
Daehan New Pharm Co. Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks Daehan New Pharm Co. Ltd's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Daehan New Pharm Co. Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for Daehan New Pharm Co. Ltd from 2011 to 2024. For live market cap and broader valuation context, see how much is Daehan New Pharm Co. Ltd worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.81x | ₩18.95 Billion | ₩34.26 Billion | ▲ +128.8% |
| 2023 | 0.79x | ₩12.57 Billion | ₩9.93 Billion | ▲ +220.5% |
| 2022 | 0.25x | ₩14.25 Billion | ₩3.51 Billion | ▼ -61.3% |
| 2021 | 0.64x | ₩16.58 Billion | ₩10.55 Billion | ▼ -8.9% |
| 2020 | 0.70x | ₩13.55 Billion | ₩9.46 Billion | ▲ +76.2% |
| 2019 | 0.40x | ₩22.89 Billion | ₩9.08 Billion | ▲ +368.9% |
| 2018 | 0.08x | ₩20.47 Billion | ₩1.73 Billion | ▼ -83.8% |
| 2016 | 0.52x | ₩8.75 Billion | ₩4.57 Billion | ▲ +5.5% |
| 2015 | 0.50x | ₩7.80 Billion | ₩3.86 Billion | ▼ -25.9% |
| 2014 | 0.67x | ₩10.02 Billion | ₩6.69 Billion | ▼ -86.2% |
| 2012 | 4.83x | ₩256.82 Million | ₩1.24 Billion | ▲ +1269.7% |
| 2011 | 0.35x | ₩3.42 Billion | ₩1.20 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow